Explore a cutting-edge presentation from the 2023 Cancer Genomics Consortium Annual Meeting that delves into the development and application of personalized sequencing assays for cerebrospinal fluid liquid biopsies in pediatric brain tumor patients. Learn about the latest advancements in this crucial field of cancer diagnostics and how these innovative techniques are revolutionizing the monitoring and treatment of brain tumors in children. Gain insights into the potential benefits and challenges of using liquid biopsies for non-invasive tumor detection and tracking in young patients.
Personalized Sequencing Assays for Cerebrospinal Fluid Liquid Biopsies in Children with Brain Tumors
Cancer Genomics Consortium via YouTube
Overview
Syllabus
Personalized sequencing assays for cerebrospinal fluid liquid biopsies in children with brain tumors
Taught by
Cancer Genomics Consortium
Related Courses
-
Comparative Analysis of RNA Expression Identifies Druggable Targets in Pediatric Solid Tumors
-
Personalized ctDNA Micro-Panels for Monitoring and Predicting Clinical Outcomes in Triple-Negative Breast Cancer
-
Concordance of Targeted Sequencing from Circulating Tumor DNA and Paired Tumor Tissue
-
Clinical Utility of NGS in Liquid Biopsy for Lung Cancer
-
Whole Transcriptome Sequencing as a Diagnostic Tool for AML
-
The Future of Cutting-Edge Genomic Technologies for Liquid Biopsy Cancer Research - Part 2
